Conclusion. The results of this uncontrolled retrospective study suggest that good long-term BP control and Background. Left ventricular hypertrophy (LVH ) is very frequent in haemodialysis patients. Only few a decrease of LVM can be achieved by continuous efforts to control hypervolaemia. The decrease in investigations have reported its regression, and only by the use of antihypertensive drugs. Because volume volume may be even more important than pressure reduction to achieve this goal. load is at least as important as pressure load, we investigated whether persistent strict volume control Key words: echocardiography; haemodialysis; hyperby ultrafiltration alone may be effective in improving tension; left ventricular hypertrophy; ultrafiltration LVH Methods. Using blood pressure (BP) and cardiac dimensions as a guide, we treated all hypertensive patients in our dialysis unit during the 3 times weekly Introduction dialysis sessions for 4 h per session with as much ultrafiltration as they could stand. If they gained too Cardiac death is up to 20 times more frequent in much weight an extra isolated ultrafiltration ( UF ) uraemic patients than in the general population [1, 2] . session was applied. Special attention was given to Left ventricular hypertrophy (LVH ) has been identified dietary salt restriction.
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as the most potent single risk factor in a general The study group of all 15 patients in whom echocarpopulation [3] , and the same applies to haemodialysis diographic assessment had been made at least 1.5 years (HD) patients [4] . It is reported that LVH is mostly previously was selected retrospectively, and we persistent and progressive, despite antihypertensive acknowledge that important confounding factors might drug treatment [5] . Only two studies demonstrated not have been controlled for.
regression in HD patients [6, 7] , but only with the use Cardiothoracic index (CTI ) was estimated on the of antihypertensive drugs. chest X-ray. Diameters of left atrium (LA), left ventGenerally the genesis and persistence of LVH in ricle systolic (LVS ) and diastolic (LVD), interventricupatients with hypertension is thought to be caused by lar septum (IVS), posterior wall (PW ), and left the pressure load imposed upon the left ventricle by ventricular mass index (LVMI ) were estimated by systemic hypertension. In HD patients, however, standard echocardiographic methods.
volume load also contributes to the maintenance of Results. Mean arterial pressure of the study group had LVH. According to the LaPlace law, volumebeen lowered by UF before the first echocardiogram increments lead to a proportional increase in wall from predialysis 136±11 to 101±14 and from postthickness in order to normalize wall stress. The accomdialysis 119±8 to 92±12 mmHg. During a mean panying increase in muscle mass, however, needs to be follow-up period of 37±11 months LVMI decreased considerably greater in volume overload as compared from 175±60 to 105±11 g/m2. CTI decreased further to pressure overload, because of the increased diameter from 48±3 to 43±4%, while significant decreases of of the left ventricular cavity. Thus although many LA (22.5±3 to 19.9±4 mm/m2), LVS (18.7±4 to other factors may be involved, slight but continued 15.9±3 mm/m2) and LVD (28.3±4 to 24.0±3 mm/m2) dilatation of the heart may be a dominant one. were seen in all patients. There also was a further Therefore we hypothesized that in HD patients in decrease in both pre-and postdialysis BP to whom an acceptable blood pressure reduction (below 116±12/73±7 and 105±7/65±3 mmHg respectively. 140/90 mmHg) has been achieved by reduction of fluid overload without antihypertensive drugs, and in whom Subjects and methods tion period started after maximal ultrafiltration had been applied and BP was below 140/90 rnmHg postdia- The total follow-up period after the first echo varied they continued to gain too much weight between dialysis, an between 19 and 76 months (mean 37±15 months). extra UF session was added, which also acted as a 'sanction' During this time, continuous efforts were made to on non-compliance. Some patients who had been told by reduce BP further if necessary. This resulted in a previous doctors 'that their blood pressure would never become normal any more' became more compliant when gradual further improvement in several of the measured they realized the benefits of our approach. Thus, mean parameters. Table 1 also shows the main results at the interdialytic weight gain of this group, which had been start of intensified treatment and at the beginning, 2.8±1.4 kg decreased to 1.6±0.8 kg as a result of these during and at the end of the observation period. efforts. Our aim was not only to normalize blood pressure, Mean predialysis BP values of the study group were but also to achieve normal cardiac dimensions as evidenced 139±20/83±11 mmHg at the beginning and 116± 10 mmHg and 105±7/65±3 mmHg respectively. This In the present study we collected all cases in whom an decrease in BP was accompanied by a decrease in the echocardiogram showing LVH at least 1.5 years before was cardiac dimensions, even if they had been within available. None of them has been treated with drugs during normal limits at the beginning. Thus cardiothoracic the follow-up period. Only patients with haematocrit levels index had been below 0.48 in half of the patients higher than 24% were admitted to the study. Fifteen patients but decreased further in every subject (mean decrease (8 men and 7 women) fulfilled these criteria. Their mean age 40±14 years. None had residual renal function. Eight of from 0.48 to 0.43). The same tendency was seen for them were on erythropoietin treatment, which had been left atrial, left ventricular systolic, and diastolic diamstarted between 6 and 18 months before the first echo. This eters, which decreased by 10, 15 and 13% respecthad resulted in an increase of haematocrit (Hct) from of ively (see Table 2 ). Despite these decreases, suggesting mean of 23.4 to 29.1% in these eight patients. The dose was some further decrease in extracellular and blood not changed during follow-up.
volume, body-weight increased slightly (mean value
The mean time on dialysis was 25±11 months. They had 53±13 kg before and 55±12 kg after treatment), been hypertensive during the early dialysis periods (predialysis blood pressures 191±20/109±7 mmHg) but at the reflecting improved nutritional state. A small but not time of the first echocardiography (as a result of the above-significant increase in haematocrit (28.4±5 to 28.6±4, mentioned policy) blood pressure was as low as could P>0.05) was also present.
possibly be achieved without severe complaints.
The most important finding was a decrease in wall Blood pressures given in this article are the mean of at thickness of the left-ventricle which concerned the least three consecutive pre-dialysis recordings (sphygmomaposterior wall (−23.4%) as well as the interventricular nometer). Haemodialysis was applied for at least 4 h thrice septum (−23%) and occurred despite a decrease m weekly, using mostly acetate dialysate with Na concentration 138 mEq/l. If necessary extra UF sessions were added. ventricular diameter. Thus the calculated ventricular Cardiothoracic index was calculated from a 2-rn chest mass index decreased dramatically from 175 to X-ray. Echocardiography was performed using a Hewlett-105 g/m2
Packard ultrasonocope with a 2.5 MHz transducer. M-mode, No significant change in left ventricular ejection two-dimensional Doppler recordings were simultaneously fraction was observed although an increase from 43 to obtained with electrocardiography according to the recom-61% was noticed in the only patient whose value was mendation of the American Society of Echocardiography.
The echocardiographist was not always the same person, but below 50% (mean value for the group were 65% before he/she was not aware of previously recorded values. Left and 68% after treatment). ventricular muscle mass (LVM ) was calculated following the equation described by Devereux and Reichek [8] : LVM= 1.04×[(IVS+LVDd+PWT )3−(LVDd)3]−136 (g).
Discussion
Statistical analysis: All results are reported according to an efficacy sample analysis. Data are expressed as mean±SD.
In terminal renal failure, both before and after the The study group was determined by means of an unpaired Student's t test for quantitative variables. For comparisons start of dialysis, LVH is frequent and initially correlates of serial changes in BP, LVMI, LA, LVD etc., repeated-with blood pressure levels [9] . Despite blood-pressure measures ANOVA was performed to examine treatment reduction by drugs and/or dialysis, LVH remains, differences and interactions according to most authors [9, 10] . Thus the possibility that factors other than hypertension are operative in Results renal patients should be considered. Changes in myocardial histology (fibrosis and decreased capillary density) have recently been described [1]. They are All of the patients had been previously hypertensive and sometimes overhydrated as evidenced by cardiac also present in uraemic animals and patients without hypertension, and may be (partly) irreversible. Factors estimated the real change. Yet this applies also to other studies [6, 7] and the observed changes were too large responsible for these changes may be hyperparathyroidism, sympathetic activity [11] , reflections of the to be explained by methodological error.
We would like to stress that we did not try to define pulse wave due to stiffened arteries [12] and anaemia. Although the mean Hct values did not change signific-'dry weight' (which is notoriously difficult!) by one single parameter, but continuously tried to decrease antly after the first echo, it cannot be excluded that the previous rise in Hct in some patients contributed blood pressure as much as possible without severe complaints. During this process the values for cardiac to improvement of LVH during the first months of observation.
volume, as measured by X ray and echocardiography, which had been within the high range of normal at the Our hypothesis was that LVH is mainly caused by fluid overload in combination with high blood pressure time of the first echocardiogram, showed a progressive further decrease during continuing treatment in every and can be brought to regression by intensified UF and occasionally isolated UF sessions. The most patient. During this period, blood pressure became increasingly easier to control. important results of our study can be deduced from Tables 1 and 2 . After a period of intensified UF (before With few exceptions the majority of authors report increased internal dimensions of left ventricle cavities the first echocardiogram was taken) we had reached acceptable blood pressure (pre-dialysis 139/83 and as being characteristic and frequent in haemodialysis patients. It is moderate in extent, the mean values lying post-dialysis 126/75 mmHg), and clear decrease in cardiac volumes. Calculated left ventricular muscle around normal upper limit [12] . Foley et al. [10] recently identified left ventricular dilatation as an mass was 175±60 g/m2, exceeding normal values considerably. After a prolonged period of HD and UF we extremely strong risk factor. This probably implies that also lesser increments of cardiac diameters have reached (without drug) a calculated left ventricular muscle mass of 105 ±39 g/m2. In this period another an unfavorable effect on hypertrophy.
In the literature most publications seem to support 38% decrease of ventricular systolic cavity volume was accompanied by a decrease of the calculated muscle irreversibility of LVH. One group of HD patients showed progression of hypertrophy and had a very mass of 40%. It is known that volume changes of the heart can lead to errors in the calculation of the LVM bad prognosis [5] . Hü ting et al. [14] followed 61 normotensive HD patients for 2.5 years and saw no [13] and consequently our results may have over-decrease in the LVH. Interestingly, left atrium dimen-uted to improvement of LVH during the first months of observation. sion increased in that group. The same group [15] described a group of patients who had been normotensIt could be argued that the 15 patients described in this study were unusually responsive to the applied ive due to excellent volume control for over 3 years, yet LVH persisted. A group of patients followed-up treatment. However, the selection criterion was based on the accidental availability of two echocardiograms, for 41 months after successful renal transplantation also showed no decrease in the degree of hypertrophy because systematic application of this technique at that time was not possible for organizational and financial [16 ] , but decrease in LVH was described in another study [17] . In our patients, like in those of the Lyon reasons. Of the remaining similarly treated 29 patients in our centre only three could not be adequately group [15, 18] some LVH persisted, probably due to irreversible changes. The remaining discrepancies in controlled without drugs (data not shown).
The fact that no hypotensive drugs were needed to the literature may be related to differences in patient populations.
control BP, while the percentage of drug-treated HD patients varies from 40 to 90% in world literature can To the best of our knowledge, only two publications reported regression of LVH in HD patients, but this only be explained by better awareness of our dialysis team of the need for volume control. Earlier publicaresult was attributed to the use of antihypertensive drugs. Canella et al. [6 ] reported on a group of eight tions indicated that at least 90% of hypertension in dialysis patients is volume dependent [19] . Since then patients who were treated simultaneously with a betablocker, a converting-enzyme inhibitor, and a calcium-this question has not been systematically investigated, but the virtual absence of hypertension in a large group channel blocker. After 24 month of treatment, decreases in BP, septum thickness (but not posterior of patients with good volume control [20] supports this view. While the latter group used long dialysis wall ), and left ventricular mass index were found. However, decrease in BP took many months to occur session, our results show that a similar result can be obtained by shorter sessions (shorter, for instance, and there was also a striking decrease in left ventricular diastolic diameter from 62.6 to 54.9 mm. This raises than sessions in the Tassin experience [20] ), provided the doctors are convinced of the necessity to reduce the question of whether it was the drug treatment or a gradual decrease in intravascular volume that was 'volume'.
Few attempts have been made to distinguish between responsible for the results. The authors indeed considered the latter possibility but found it unlikely because the factors of 'pressure' and 'volume' or to identify volume retention as an independent risk factor. There interdialytic weight gains were the same as in the control group. However, interdialytic weight gain is an is no doubt that 'silent' overhydration persists in many HD patients [21] . A recent review [22] came to the indication of the patients' compliance, not of absolute volume control.
conclusion that same applies to CAPD patients: LVH did not regress during this treatment but is rapidly London et al. [7] compared the effect of two different drugs, a converting enzyme inhibitor and nitrendipine reversed after transplantation.
If volume-induced hypertension can be controlled over 12 months, in a carefully conducted prospective study. A similar decrease in mean arterial pressure to by hypotensive drugs, the overhydration may not be corrected. In other words, lowering BP without cor-107 and 109 mmHg respectively was achieved. This resulted in significant decrease in LV mass index of recting volume may be less effective in reducing LVH.
On the other hand, decrease in LVH may facilitate −25% in perindopril-treated patients only. There was, however, also a striking decrease in LV diastolic dia-blood-pressure control because LVH leads to decreased diastolic compliance, which favours sudden drops in meter from 54.3 to 49.9 mm in that group, while this value remained the same in the nitrendipine-treated blood pressure during ultrafiltration, making achievement of 'dry weight' more difficult. Such circulatory group. The authors attribute this to a decrease in preload caused by dilatation and increased compliance instability is also enhanced by antihypertensive drugs.
These considerations are supported by the further of the venous system. In other words some permanent redistribution of the blood volume was postulated. decrease in blood pressure along with the progressive decreases in volume and muscle mass observed by us. This result is very similar to that of Canella and a gradual decrease in blood volume may also have Our results illustrate that strict volume control not only decreases blood pressure, but also that it takes occurred in this study, somehow facilitated by the converting-enzyme blockade. Anyhow both studies time and continuous efforts to reduce dilated cardiac compartments, which in turn facilitates blood pressure support the importance of decreased left ventricular volume for the regression of hypertrophy.
control, as was also emphasized by others [20] . The present study shows both the feasibility and the benefiThe decreases reported in the present study were more pronounced. More importantly they were cial effects of such efforts. obtained without the use of antihypertensive drugs. It is well known that correction of anaemia can cause References regression of hypertrophy in dialysis patients. Although the mean Hct values did not change signific-1. Amann K, Ritz E. Reduced cardiac ischaemia tolerance in antly after the first echo, it cannot be excluded that uraemia-what the is role of structural abnormalities of the heart? Nephrol Dial Transplant 1996; 11: 1238-1241 the previous rise the in Hct in some patients contrib-
